Tyler Scheiner
Lawyers
Filters
Galaxy C$169.4 million offering of ordinary shares
We advised Galaxy on its offering
Nurix Therapeutics $175 million stock and pre-funded warrants offering
The stock is listed on the Nasdaq Global Market
AbbVie $15 billion senior notes offering
The investment-grade offering comprised seven tranches
Global Payments $2 billion convertible senior notes offering
The 1.5% convertible notes are due 2031
Ankura Consulting Group acquisition of Lumeri
We are advising Ankura on the acquisition
Sun Country Airlines Holdings $64 million secondary offering
The shares are listed on the Nasdaq Global Select Market
Mallinckrodt emerges from chapter 11
We advised an ad hoc group of first-lien noteholders
Sibanye-Stillwater $211.5 million acquisition of Reldan
We are advising Sibanye-Stillwater on the acquisition
Bridgepoint sale of DMC Power to Golden Gate Capital
We advised Bridgepoint on the transaction
Ocyan completes $2.7 billion cross-border restructuring
We advised Ocyan in connection with the restructuring